CapsoVision (CV) Interest & Investment Income (2024 - 2026)
CapsoVision (CV) posted Interest & Investment Income of $94000.0 for Q4 2025, down 28.79% sequentially from $132000.0 in Q3 2025, and up 2250.0% YoY from $4000.0 in Q4 2024.
CapsoVision (CV) Interest & Investment Income (2024 - 2026) Analysis & Trends
CapsoVision has reported Interest & Investment Income for 2 years, with the latest figure at $94000.0 in Q4 2025.
- Quarterly Interest & Investment Income rose 2250.0% year-over-year to $94000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $267000.0 (changed N/A YoY) and the FY2025 annual result came in at $269000.0, up 934.62% from the prior year.
- Interest & Investment Income declined to $94000.0 in Q4 2025 per CV's latest filing, from $132000.0 in the prior quarter.
- Over five years, Interest & Investment Income peaked at $132000.0 in Q3 2025 and troughed at $4000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.60 Bn | 194.00 Bn | 7.27 Bn | 52.00 Mn |
| 2 | Stryker | 127.14 Bn | 123.66 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.89 Bn | 109.67 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 73.11 Bn | 72.57 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 52.03 Bn | 47.78 Bn | 1.35 Bn | 30.00 Mn |
| 6 | Dexcom | 34.31 Bn | 32.36 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.78 Bn | 31.67 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 73.23 Mn |
| 9 | Steris | 23.03 Bn | 22.55 Bn | 684.20 Mn | - |
| 10 | CapsoVision | 298.13 Mn | 289.05 Mn | 1.87 Mn | 82,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 82,000.00 |
| Dec 31, 2025 | 94,000.00 |
| Sep 30, 2025 | 132,000.00 |
| Jun 30, 2025 | 37,000.00 |
| Dec 31, 2024 | 4,000.00 |
| Sep 30, 2024 | 8,000.00 |
| Jun 30, 2024 | 5,000.00 |